Characterization of plasmids carrying blaCTX

Scientific Reports volume 13,

Scientific Reports volume 13, Article number: 8595 (2023) Cite this article

421 Accesses

1 Altmetric

Metrics details

CTX-Ms are encoded by blaCTX-M genes and are widely distributed extended-spectrum β-lactamases (ESBLs). They are the most important antimicrobial resistance (AMR) mechanism to β-lactam antibiotics in the Enterobacteriaceae. However, the role of transmissible AMR plasmids in the dissemination of blaCTX-M genes has scarcely been studied in Africa where the burden of AMR is high and rapidly spreading. In this study, AMR plasmid transmissibility, replicon types and addiction systems were analysed in CTX-M-producing Escherichia coli clinical isolates in Ethiopia with a goal to provide molecular insight into mechanisms underlying such high prevalence and rapid dissemination. Of 100 CTX-Ms-producing isolates obtained from urine (84), pus (10) and blood (6) from four geographically distinct healthcare settings, 75% carried transmissible plasmids encoding for CTX-Ms, with CTX-M-15 being predominant (n = 51). Single IncF plasmids with the combination of F-FIA-FIB (n = 17) carried the bulk of blaCTX-M-15 genes. In addition, IncF plasmids were associated with multiple addiction systems, ISEcp1 and various resistance phenotypes for non-cephalosporin antibiotics. Moreover, IncF plasmid carriage is associated with the international pandemic E. coli ST131 lineage. Furthermore, several CTX-M encoding plasmids were associated with serum survival of the strains, but less so with biofilm formation. Hence, both horizontal gene transfer and clonal expansion may contribute to the rapid and widespread distribution of blaCTX-M genes among E. coli populations in Ethiopian clinical settings. This information is relevant for local epidemiology and surveillance, but also for global understanding of the successful dissemination of AMR gene carrying plasmids.

Antimicrobial resistance (AMR) is an acute problem of the global healthcare system1. The issue is typically associated with the extensive Enterobacteriaceae family2. In this bacterial family, extended-spectrum β-lactamases (ESBLs) are the primary AMR mechanism nullifying β-lactam type antibiotics. CTX-Ms encoded by the blaCTX-M genes are the most dominant and widespread ESBL enzyme types, with Escherichia coli being a major source of their production3,4. Tracking of CTX-Ms-producing E. coli is challenging, and requires in-depth investigation of the underlying dissemination mechanisms, clinical implications, and overall epidemiology of the blaCTX-M genes.

Bacterial plasmids are vital mobile elements for horizontal transfer between different bacterial species of exogenous genes including AMR genes. This has been extensively investigated in high-income countries5,6. The incompatibility (Inc) group F (IncF) which belongs to the narrow-host-range plasmids is the most relevant to AMR gene transmission7. Horizontal spread of AMR plasmids also plays an important role in the acquisition of virulence encoding genes8. For instance, ESBLs-encoding plasmids are associated with enhanced virulence potential in pandemic E. coli sequence type (ST) 131 strain and other pathogenic E. coli9.

In Africa, despite the high burden of ESBL-producing E. coli10, there exists little knowledge of the underlying molecular mechanisms, virulence associated factors and overall plasmid-mediated AMR epidemiology. Without unambiguous and up-to-date data on this, effective tracking and management of virulent E. coli is not feasible. We have recently published a phenotypic characterization of CTX-M-positive E. coli clinical isolates from four geographically distinct healthcare settings in Ethiopia11. The study reported on the different E. coli phylo-groups with several isolates belonging to the international high risk ST131 clone11. It also revealed the presence of alternative β-lactamase gene carriage in certain isolates and obvious multidrug resistance (MDR) among them11. It is of interest to know if these characteristics are transferrable to recipient E. coli strains through transmissible AMR plasmids.

To limit the effectiveness of plasmid transmissibility, and thereby the spread of MDR, it is first necessary to understand the biology of the existing AMR plasmids. To our knowledge, this has not been conducted on plasmids identified in clinical E. coli isolates from Ethiopia. Hence, in this study we began this important work by focusing first on transferability of AMR plasmids and identifying the plasmid replicon types among the clinical isolates used in our previous study. This study also investigated the association between the ISEcp1 element and blaCTX-M genes because this insertion system element is commonly found adjacent to the CTX-M encoding genes on transmissible plasmids, and plays an important role in chromosomal capture, mobilization, and expression of the AMR genes from the transmissible plasmids6,7,12. We also assessed the presence of eight plasmid encoded addiction systems since plasmid maintenance during host replication is a vital aspect of transmissibility13,14. Finally, because plasmid replication, maintenance, and transfer are influenced by bacteria living in biofilm communities15 and that AMR plasmid carriage impacts on serum resistance16, an important virulence property of pathogenic E. coli strains17, these associations were also investigated in the current study. By doing so, this study is the first to describe the biology of the existing AMR plasmids among clinical E. coli isolates from Ethiopia and can therefore contribute important knowledge of processes leading to the rapid dissemination of MDR, and that can then be identified as targets for inhibition.

To determine the molecular basis for the spread of CTX-M genes, we semi-randomly selected 100 CTX-M producing isolates from the original study11 (Supplementary Table S1). The basis for study inclusion were the criteria (1) all isolates must be CTX-M producing, (2) all geographical study sites must be represented [NRL (National reference laboratory)—36; TASH (Tikur Anbessa Specialized hospital)—31; ARH (Ayder Referral Hospital) 19; JUH (Jimma University Hospital)—14], and (3) all phylogenetic groups must be represented [phylogroup A (19); B1 (4); B2 (52); C (16); D (5), and F (4)] (Table 1). We were able to demonstrate that 75% (n = 75) of these clinical isolates had the ability to transfer genes encoding CTX-M determinants to E. coli J53 AziR by conjugation or to E. coli HB101 by chemical transformation (Table 1). Of the 75 isolates that demonstrated transmissibility, the gene encoding for CTX-M-15 was represented in 51 isolates (68.0%), other group-1 CTX-M genes were in 17 isolates (22.7%), and group 9 CTX-M genes in 7 isolates (9.3%) (Table 1). Of the 25% (n = 25) of clinical isolates where transmissibility could not be demonstrated, we identified CTX-M encoding genes among five phylo-groups, and the blaCTX-M-15 gene in B2-ST131 isolates was dominant (Table 1). Sequencing of the amplified DNA fragments confirmed an association between the ISEcp1 and blaCTX-M genes. Strikingly, 73 of the 75 parental isolates (97.3%) and 71 (94.7%) of the recipient strains were positive for the ISEcp1 element.

Alternative β-lactamase-encoding genes (non-ESBLs genes) were detected in 72 of the 75 isolates that could transmit AMR genes to recipient bacteria. Specifically, blaTEM-1, blaOXA-1 and blaTEM-OXA genes were detected in 13 (17.3%), 16 (21.3%) and 39 (52%) of the 75 original parental isolates respectively (Table 2). The ESBL blaSHV gene was detected in 4 (5.3%) isolates. Three isolates (4%) were devoid of all four of these alternative β-lactamase-encoding genes. These same genotypes were characterized in the plasmid recipient strains. The blaTEM-1, blaOXA-1 and blaTEM-OXA genes were detected in 23 (30.7%), 13 (17.3%) and 26 (34.7%) of the recipient strains receiving mobilised AMR plasmid(s), respectively (Table 2). The remaining 13 (17.3%) recipient strains did not acquire any of these genes. Furthermore, not a single recipient strain gained the ESBL blaSHV gene (Table 2).

We had previously assessed multiple drug resistance profiles among the parental clinical isolates used in this study11 (Supplementary Table S1). To address whether this characteristic could be conferred to recipient bacteria through the transmissibility of AMR plasmids, we performed an antimicrobial susceptibility test using the disk diffusion method on all 75 parental clinical isolates and their corresponding recipients of AMR plasmids. The 75 isolates were 100% resistant to cefotaxime, ceftazidime and cefepime confirming our earlier finding11. Among second-generation plasmid recipient strains this resistance rate remained 100% for cefotaxime and dropped slightly to 90.7% and 88.0% for ceftazidime and cefepime respectively (Fig. 1). The resistance rates for ciprofloxacin, sulfamethoxazole/trimethoprim amoxicillin-clavulanic acid, gentamicin, cefoxitin, amikacin and meropenem were 92.0%, 88.0%, 72.0%, 50.7%, 17.3%, 1.3% and 1.3%, respectively (Fig. 1). Among the AMR plasmid recipient strains, resistance rates to these non-β-lactams antibiotics were 48%, 65.3%, 41.3% and 1.3% for ciprofloxacin, sulfamethoxazole/trimethoprim, gentamicin, and amikacin respectively (Fig. 1). Moreover, 56% of the second-generation strains were resistant to the β-lactamase inhibitor amoxicillin-clavulanic acid and 9.3% were resistant to cefoxitin, whereas no strain acquired resistance to meropenem (Fig. 1).

Comparison of the percent antibiotic resistance displayed by 75 original isolates and the corresponding plasmid recipient strains. Recipient strains are based upon either the E. coli J53 AziR background and achieved via conjugal mating (transconjugates) or the E. coli HB101 background achieved via chemical transformation (transformants). The percent resistance of the different parent (dark grey bars) and recipient (light grey bars) isolates was according to the CLSI disk diffusion breakpoints. Resistance was defined as isolates with intermediate resistance and complete resistance based upon the size of the inhibition zone compared to the reference strains ESBL negative E. coli ATCC 25,922 and ESBL positive K. pneumoniae subsp. pneumoniae ATCC 700,603. Antibiotics tested were amoxicillin-clavulanate (AMC), cefotaxime (CTX), ceftazidime (CAZ),), cefepime (CEF), cefoxitine (FOX), ciprofloxacin (CIP), Amikacin (AMK), gentamicin (GEN), Meropenem (MEM), Sulphamethoxazole-Trimethoprim (SXT).

To our knowledge, the biology of AMR plasmids harboured by clinical bacterial isolates from Ethiopia has not been studied. We began this important work by focusing first on identifying the plasmid replicon types among the isolates used in our study by adopting an established PCR based replicon typing (PBRT) protocol18. Of the 75 transferred CTX-M ESBLs-encoding plasmids, replicons of 64 (85.3%) were typed and revealed four Inc groups categorized into 13 different combinations (Fig. 2). The IncF plasmids with various replicon types were the most numerous combinations among all the plasmids. The plasmid F-FIA-FIB replicon groups were the most frequently identified (42.2%) with 27 of the 64, followed by the combination of FIA-FIB (9.4%) (Fig. 2). The replicon types F-FIB-I1-Iγ, F-FIB as well as IncF replicon types were all detected at a frequency of 7.8%, and the I1-Iγ replicon type at 6.3% (Fig. 2). The other types identified were detected at below 5% frequency in the plasmid recipient strains (Fig. 2).

Frequency of plasmid replicon types originated from E. coli isolates obtained from clinical samples collected from healthcare centers in Ethiopia. Of 75 recipient strains receiving one or more plasmids via conjugation or transformation, 64 contained plasmids that could be typed by the chosen PCR-based method. IncF based replicon types were most identified.

We also determined the association of replicon types with antibiotic resistance genes. Out of the 51 transmissible plasmids having blaCTX-M-15 (see Table 1), 45 (88.2%) were typed using PBRT. Among these 45 PBRT-typed transmissible plasmids, 35 (77.8%) carried combinations of Inc replicon types while the remaining 10 (22.2%) carried just a single replicon type (Table 3). The combination of F-FIA-FIB plasmid replicon was frequently associated with other group-1 CTX-M types encoded by blaCTX-M-101, blaCTX-M-103, blaCTX-M-142, blaCTX-M-180, blaCTX-M-182 and blaCTX-M-225 (Table 3). In addition, 6 plasmids carrying group-9 blaCTX-M-27 belonged to 3 different replicon types consisting of a single IncF (n = 1), as well as in apparent combination with F-FIA-FIB (n = 4), or with F-FIA-FIB, and I1-Iγ (n = 1) (Table 3).

In contrast, the PBRT protocol was unable to type into any of the 18 incompatibility groups the remaining 11 (14.7%) of 75 isolates containing transmissible plasmids carrying blaCTX-M genes. Of these untyped 11 isolates, 6 (54.5%) contained a plasmid carrying blaCTX-M-15, 4 (36.4%) had a plasmid having genes encoding for other group-1 CTX-Ms (1 blaCTX-M-55, 2 blaCTX-M-180, 1 blaCTX-M-182) and 1 (9.1%) with plasmid carrying group-9 blaCTX-M-14 (Table 3).

Plasmid maintenance during host replication is a vital aspect of transmissibility. We investigated the presence of eight plasmid encoded addiction systems according to a previously described PCR-based detection system19. Six plasmid addiction system types (pemKI, ccdAB, vagCD, hok-sok, pndAC and srnBC) could be identified among the 75 parental isolates (Table 4) and the corresponding plasmid recipient strains (Table 5). In the parental strains, the 337 plasmid addition system combinations detected were pemKI (n = 72), srnBC (n = 68), ccdAB (n = 68), vagCD (n = 55), pndAC (n = 48), and hok-sok (n = 26). The relBE and parDE plasmid addiction systems were not detected in the parental E. coli strains analysed. On the other hand, in the plasmid recipient strains, a total of 176 plasmid addiction system combinations were identified consisting of pemKI (n = 47), srnBC (n = 42), ccdAB (n = 39), vagCD (n = 21), pndAC (n = 23), and hok-sok (n = 4). Once again, none of the strains harboured the relBE and parDE plasmid addiction systems.

There was direct correlation between the combination of plasmid replicon types and the mean numbers of addiction systems detected (Table 3). The highest mean numbers of addiction systems were observed in plasmids with a combination of four replicon types. In contrast, the lowest mean numbers of addiction systems correlated to plasmids with a single Inc replicon type. However, no clear correlation between any of the mean numbers of plasmid addiction system combinations and any β-lactamase type including the CTX-M in either the donor parental strains (Table 4) or the recipient strains (Table 5) could be identified.

Knowledge of the interplay between bacterial biofilms and plasmids could benefit the development of therapeutic measures to control antimicrobial resistance plasmid transmissibility. Hence, we compared the ability of 12 donor parent strains and the corresponding plasmid recipient counterparts for their ability to form biofilms in a microtiter plate assay. The criteria for selecting this subset were: (1) a primary focus on the B2 phylotype because these are usually extra-intestinal bacteria, (2) a primary focus on the ST131 international high risk clone, (3) a spread of isolates having one to multiple plasmid replicon types, (4) a spread of isolates having one to multiple CTX-M types, and (5) all geographical study sites must be represented [NRL (National reference laboratory)—4; TASH (Tikur Anbessa Specialized hospital)—3; ARH (Ayder Referral Hospital)—3; JUH (Jimma University Hospital)—1] (Supplementary Table S1). Only two donor parental ‘P’ strains could be classified as a strong biofilm former—P106, or moderate biofilm former—P107 (Fig. 3). The remaining donor parental strains were either weak biofilm formers (P2, P3, P22, P154, P163, P174, and P184), or failed to form biofilms (P9, P74 and P149) under the experimental conditions tested (Fig. 3). Interestingly, only the plasmids transmissible from P22, P154 and P184 plasmid could confer to the recipient ‘R’ strains (R22, R154 and R184) the ability to form any degree of biofilm (Fig. 3). The replicon types identified in these three isolates were F-FIB, F-FIA-FIB and F-FIA-FIB, respectively (Supplementary Table S1). Hence, we could identify just three cases where the P22, P154 and P184 derived AMR plasmid(s) may have captured plasmid-encoded biofilm promoting factors.

Biofilm formation efficiency of pathogenic E. coli strains, isolated from Ethiopian patients. Data was generated from a minimum of three biological and three technical replicates for every isolate and plotted using GraphPad-5.0. One-way ANOVA with inbuilt Tukey's multiple comparison test was applied to calculate statistically significance between control strain E. coli J53 (black bar) and Parental strains (‘P’, dark grey bars) and respective recipient strains (‘R’, light grey bar). P < 0.0001: ***P < 0.001: **P < 0.01: *P > 0.05: non-significant (ns).

Since carriage of AMR plasmids influence the extent of serum resistance16, we compared the ability of a selected group of donor parent strains and the corresponding plasmid recipient counterparts for their ability to confer resistance to normal human serum. Ten of the isolates selected above were also used in this serum sensitivity study (Supplementary Table S1). Two parental ‘P’ isolates (P9 and P74) and four recipient ‘R’ strains (R2, R9, R74 and R106) were totally sensitive to prolonged exposure to human serum (Fig. 4). This was comparable to the serum sensitive phenotype of the control strain E. coli J53. On the other hand, 8 parental strains (P2, P3, P22, P106, P107, P154, P163, and P174) and 6 recipient strains (R3, R22, R107, R154, R163, and R174) displayed extensive serum resistance. Hence, serum resistance in the strains P3, P22, P107, P154, P163, and P174 is influenced by transmissible AMR plasmid carriage. The replicon types identified in these six isolates were F-FIA-FIB-I1, F-FIA-FIB, F-FIA-FIB, F-FIA-FIB, W and F-FIA-FIB, respectively (Supplementary Table S1). In contrast, serum resistance in the strains P2, and P106 is not transmissible and must be associated with chromosomal encoded elements or elements encoded on non-transmissible plasmids.

Survival efficiency of pathogenic E. coli strains grown in the presence of serum. Survival properties of 10 parental clinical isolates (dark grey bars) and their corresponding recipient strains (light grey bars) and the control strain J53 (black bar) after exposure to active human serum for 0 and 3 h. The susceptibility to killing was calculated as follows: log kill = (log10 CFU per milliliter of initially added bacteria—0 h)—(log10 CFU per milliliter of bacteria surviving the incubation after 3 h). GraphPad-5.0 was used to plot data from a minimum of two biological replicates of every isolate. Means and standard errors of the results are shown. One-way ANOVA with inbuilt Tukey's multiple comparison test was applied to calculate statistical significance between the corresponding parental and recipient strains. P < 0.0001: ***P < 0.001: **P < 0.01: *P > 0.05: non-significant (ns).

This study is the first to report on plasmid transmissibility, replicon types and associated addiction systems among CTX-M-producing MDR E. coli clinical isolates from Ethiopia (Supplementary Table S1). It is also the first study from Ethiopia that describes these plasmid replicon types in association with the clonal distribution of CTX-M-producing E. coli clinical isolates. The data verify the long-held notion that horizontal gene transfer is a major contributor to the clonal expansion and widespread distribution of CTX-M-encoding genes in Ethiopia. These findings are alarming for it demonstrates that plasmid transmission is a major factor in the co-transfer of genes encoding resistance to non-cephalosporins antimicrobials among bacterial populations in Ethiopia. Consequently, in the absence of any intervention rapid spread of multiple drug resistance among bacterial populations in clinical, agricultural and community settings will continue unabated. An uneasy solace is for last resort carbapenem drugs, such as meropenem, where the isolates were still highly susceptible. Possible resistance to colistin, which is a last-resort treatment for MDR Gram-negative infections, was not tested because it was not approved for clinical use in Ethiopia at the time of the study.

While 75% of the isolates examined contained CTX-M genes on transmissible plasmids, the remaining 25% of isolates were unable to transfer these genes to the E. coli recipient. Moreover, the alternative β-lactamase blaSHV was also non-transmissible. These non-transferable blaCTX-M and blaSHV genes are likely to be integrated into the host chromosome or be present on non-transmissible plasmids. These isolates are worthy of further genetic characterization as it may provide some new clues on the increased genetic heterogeneity among the markers for MDR and their dissemination. A precedent for this type of novel discovery is the chromosomal location of blaCTX-M-15 in the very extensive AMR and virulent subclone of ST131 H30Rx20. This origin was due to the mobilization of a plasmid-located Tn3-like ISEcp1-blaCTX-M-15-orf477 element that subsequently integrated into the bacterial genome. ISEcp1 is an IS that contributes to the effective capture, expression, and mobilization of AMR genes from multiple sources, and is commonly located in the upstream of region of the CTX-M encoding genes21,22. Our observation of ISEcp1 in 97.3% of parental strains and 94.7% of the corresponding recipient strains corroborates these earlier findings.

Although exact genetic associations could not be directly determined without plasmid sequencing data, 59 (78.7%) transferrable blaCTX-M genes appeared to be located on narrow-host-range IncF plasmids. This agrees with IncF plasmids being the major carrier of blaCTX-M genes23. IncF plasmids encoding for CTX-Ms are detected in a range of E. coli sequence types24, but have a particularly strong association with the global spread of CTX-M-15 producing E. coli ST13123. IncF plasmids contribute various AMR determinants and virulence associated factors that create competitive fitness advantages that select for the success of the ST131 clone25, and the evolution of ST131 sub-lineages such as H30, which include H30R1 and H30Rx7,25,26. Consistent with this profile is our observation of IncF plasmids harboured by isolates associated with a variety of E. coli sequence type lineages, including the international high risk E. coli ST131 lineage. This indicates that the widespread prevalence of CTX-M-15 encoding genes in Ethiopia is facilitated by both host cell clonal expansions and horizontal gene transfer by IncF plasmids. We also identified IncF plasmids in E. coli phylogenetic groups primarily considered to be commensal E. coli, corroborating an earlier claim27.

We suspect that the IncF plasmids identified in this study have either single replicons or multiple replicons. The different combinations can reflect the fusion between different types creating a replicon chimera, or that multiple plasmids simultaneously coexist in the same cell18,24,28,29. This phenomenon is quite helpful to establish and trace relevant epidemiologic plasmid lineages. However, the fitness advantages conferred by a plasmid having multiple replicons within the same incompatibility group is not clear, since it surely would raise issues of replication coordination, regulation, and instability brought about by incompatibility phenomena. This contrasts with plasmids co-opting replicons from different incompatibility groups, which would extend replication opportunities within diverse hosts. Hence, follow-up work focused on whole genome or plasmid sequencing should assess if the IncF plasmid replicons represent discrete and intact genetic entities, or whether they are merely fusions between different types creating replicon chimeras, as has been previously reported18. Assessing replicon functionality is also warranted.

Interestingly, from eight addiction system types analysed in this study, we could detect three type I and three type II addiction systems. In the parental donor isolates this amounted to 337 combinations of addition systems. However, just 176 addiction system combinations were detected in the recipient transconjugants. As suggested by others, the implication of these findings is that addiction systems might be positioned on a non-conjugative plasmid or in the chromosome, and those located on conjugative plasmids are associated with the transmissible blaCTX-M genes19,30,31. Moreover, almost all detected addiction systems in the recipient strains were carried on IncF plasmids, corroborating previous findings32. Plasmid addiction systems play important roles in plasmid stability and maintenance in a bacterial population33, and can enhance bacteria fitness under adverse environmental conditions34. Hence, our data indicate that IncF plasmids use multiple addiction systems for maintenance and stability during horizontal dissemination of blaCTX-M genes within Ethiopian isolates.

An additional key element to this is the finding that these blaCTX-M harbouring plasmids also possess the possibility to disseminate other resistant genes of clinical significance, including those that confer resistance to sulfamethoxazole/trimethoprim, ciprofloxacin, amoxicillin-clavulanic acid, gentamicin, amikacin, and cefoxitin. This highlights the potential of plasmids harbouring blaCTX-M genes to quickly disseminate MDR in hospital, community, and agricultural settings. Thus, a better understanding of the origin and evolution of non-beta-lactam antibiotics resistance in Ethiopia is required.

Despite our identification and initial characterization of transmissible AMR plasmids in E. coli isolates collected at limited healthcare settings, it is evident that pivotal knowledge concerning the genetic diversity that might exist among them is still lacking. Follow up work should focus on further genetic characterization of the plasmids to better define the extent of their diversity, and to provide important information connecting plasmid backbone and replicon type with combinations of acquired multiple resistance genes and addiction modules as well as other phenotypic traits associated with pathogenicity such as serum resistance and the capability to form biofilms. Achieving this would require a method that combines S1-nuclease mediated cleavage of the plasmids, followed by pulsed field gel electrophoresis and Southern blotting35, and also in combination with direct plasmid sequencing, or even through whole genomic sequencing. Considering that most transmissible plasmids in this study were based on the IncF family, which in other studies has displayed extensive genetic diversity36,37,38,39 we speculate that this would be true also for plasmids harboured in our isolate collection. Moreover, a significant percentage of transmissible plasmids possessed a non-typed replicon according to our PBRT assay. Hence, applying the more discerning genetic methods on this group of isolates will also provide new clues concerning dissemination of AMR among various E. coli populations in Ethiopia.

Apart from the IncF plasmids, we were also interested in the isolates that harboured transmissible narrow-host-range plasmids with an IncI1-Iγ or IncY replicon. Although not confirmed by sequence-based methods, the IncI1-Iγ and IncY plasmids identified in our study were often found associated with the blaCTX-M-15 gene. Interestingly, plasmids with these replicons have been detected in bacteria isolated from animals produced for food and associate with various AMR genes40,41,42,43. Based on this precedent, it is possible that the IncI1-Iγ and IncY plasmids identified herein may have an animal origin, which could be a source for human infections in Ethiopia. This will be confirmed in future work with Ethiopian bacterial collections expanded to include isolates from wider community and agricultural sources. The only other replicon detected in our study was IncL/M. This is a broad-host-range replicon allowing for greater transmission among diverse bacterial species, as evidenced by an association between IncL/M plasmids and blaCTX-M-3 and blaOXA-48 dissemination44,45.

Various E. coli pathotypes possess a variety of virulence associated factors which support their entry, colonization, survival, and dissemination within and between infected human and animal hosts. Definitive conclusions concerning pathotypes of our isolates still require sequence analysis to identify the presence of hallmark virulence genes that have been defined in earlier studies46,47,48. It is well established that virulence associated factors can be encoded within mobile genetic elements, such as plasmids49. This is also reflected in this study that revealed survivability of a subset of parental isolates and their corresponding plasmid recipient strains in normal human serum, which is attributable to specific genes carried on the CTX-M-encoding resistance plasmids. Although the data is limited, it hints to the fact that AMR plasmids from many E. coli isolates sourced in Ethiopia likely also encode for other properties that can influence lifestyle choices important for environmental survival and host pathogenicity.

We also noted that most isolates containing the blaCTX-M-14, blaCTX-M-15 and blaCTX-M-27 genes distributed among the B2, D, and F phylo-groups. These likely represent extra-intestinal pathogenic E. coli (ExPEC) isolates, since global population studies routinely associate ExPEC bacteria within the B2 and D phylo-groups50. This is a serious concern given that ExPEC bacteria are a major global clinical problem51. Hence, we speculate a high prevalence of ExPEC in Ethiopia, although this needs to be verified on more extensive E. coli collections. This will be achievable because of our access to a diverse and expanding E. coli isolate collection via ongoing One Health laboratory-based AMR surveillance initiative in Ethiopia. The identification of virulence associated factors co-localising with plasmid-encoded AMR genes will have major ramifications for the evolution of novel and re-emerging bacterial pathogens that will pose acute health risk.

There is also interest in the isolates associated with the phylogenetic groups A, B1 and C which are unlikely to be ExPEC strains. Rather, they must be either intestinal non-pathogenic commensal isolates, or intestinal pathogenic isolates (InPEC). Either way, they have been isolated from non-stool samples, chiefly urine, suggesting an association with extra-intestinal infections, and which would require a translocation from the gastrointestinal tract. Since InPEC rarely caused extra-intestinal infections52, we suspect that the remaining extra-intestinal isolates belonging to the other phylogenetic groups A, B1 and C originated as commensal E. coli. This idea needs confirmation, but precedent comes from knowing that commensal E. coli strains can participate in extra-intestinal infections when the gastrointestinal barrier is breached especially in immune-compromised patients and when the bacterial load is particularly high53.

Our study has certain limitations. It did not directly determine which blaCTX-M genes were genetically linked with the identified plasmid replicon types. Genetic characterization of the isolates that did not transfer blaCTX-M genes was also not performed. Further, reliable genetic associations could not be directly inferred without plasmid sequencing data. Moreover, our identification and initial characterization of transmissible AMR plasmids in E. coli isolates were collected from limited healthcare settings and does not have nationwide representation. Thus, the results need confirmation in future work on collections expanded to include isolates from wider communities and agricultural sources. In future studies, the relationship between efficacy of plasmid transfer and the genetic features of the plasmids will be scrutinised, for this information will be relevant not only for epidemiologists and Ethiopian surveillance but also for the global scientific community to associate the success of the spread and dissemination of an antibiotic resistance gene with a plasmid type and mobility.

In conclusion, we report a high prevalence of IncF-like plasmids that might be involved in the mobilization of CTX-M and other AMR genes in Ethiopia. Mostly identified from the international successful ST131 lineage, these plasmids harbour the ISEcp1 element for effective gene capture as well as multiple addiction systems to select for plasmid maintenance in daughter cells. The data indicate the underlying molecular basis for the previously reported extensive prevalence of blaCTX-M-15 in Ethiopia11. Knowledge of the role of transmissible plasmids in the spread of AMR genes among extra-intestinal E. coli populations in Ethiopia is an important step. Not only will it help strengthen national infection prevention and control systems, but it also opens up the possibility of developing therapeutic strategies to target bacteria harbouring such plasmids to limit their subsequent acquisition and transmission of AMR within bacterial populations54,55. Overall, the data represent high AMR plasmid carriage among CTX-M ESBL-producing E. coli isolates from four facilities in Ethiopia. As a result, the potential for plasmid transmissibility is very high, as is the likelihood of further rapid spread of AMR genes of diverse families.

The isolates were retrieved from a biobank after having been collected in 2018 from four geographically distinct facilities as part of ongoing national AMR surveillance initiative. The initiative was launched in 2017 by the EPHI under the supervision of the Ministry of Health and operates under the auspices of the World Health Organization Global AMR and Use Surveillance (GLASS) initiative (https://www.who.int/initiatives/glass). Detailed sample collection procedure including patient inclusion and exclusion criteria is reported elsewhere11,56 and strictly adhered to standard practices for clinical microbiological sampling established by the Ohio State University Global One Health initiative57. All in the biobank are clinical isolates and not isolates from the general population or other epidemiologic scenarios.

Initial phenotypic characterization, strain screening, phylo-typing as well as β-lactamase gene detection and antibiotic susceptibility testing were reported for 204 ESBLs-producing E. coli clinical isolates in our recent study11. In the current investigation, we considered 100 CTX-Ms-producing isolates obtained from urine (n = 84), pus (n = 10) and blood (n = 6) from the original set. It was sufficient to focus on just 100 isolates because all the CTX-Ms-encoding gene types identified in our initial study were included within this sub-collection. However, the over-representation of isolates from urine suggests that most of these strains will be enriched for virulence factors associated with genitourinary invasion. Moreover, we have no data on the antimicrobial exposure at the time of collection. This can be relevant because it is conceivable that certain patients from whom the isolates were obtained were receiving antimicrobial therapy, creating potential for bias toward over-representation of certain antimicrobial resistance genes.

The study was approved by the EPHI Scientific and Ethical Review Board (EPHI-IRB-054–2017) and the College of Natural and Computational Sciences Institutional Review Board, Addis Ababa University (CNS-IRB/039/2019). As all bacterial isolates included in this study were sourced from a biobank, the study did not directly involve patients, human material, or personal data identifiers.

Plasmids were transferred by either the conjugation or chemical transformation method. Conjugation was performed by a mating assay using E coli J53 AziR as recipient strain58. Trans-conjugants were selected on Luria-Bertani agar (LA) plates containing sodium azide (150 µg/mL) and cefotaxime (2 µg/mL). This necessitated that all donor strains were pre-tested for susceptibility to sodium azide and E coli J53 AziR was pre-tested for susceptibility to cefotaxime. If plasmids were non-conjugative, chemical transformation was performed using the recipient strain E. coli HB101 (Promega, Sweden). Plasmids were purified using the GeneJET plasmid miniprep kit (Thermo Fisher Scientific Inc.) and transformed into the chemically competent recipient strain using heat shock at 42 °C. Transformants were selected on LA plates supplemented with cefotaxime (2 µg/mL).

Isolates were analysed for the presence of ESBL-encoding genes blaTEM, blaSHV, blaCTX-M and blaOXA using a combination of established PCR and sequencing methods as previously described59. Purified PCR products were sequenced using the service of Eurofins genomics (Ebersberg, Germany). The β-lactamase gene types were identified by alignment with sequences in GenBank using BLAST (http://www.ncbi.nlm.nih.gov/BLAST). Antibiotic susceptibility testing was done for 10 antibiotics against transferable parental isolates and their corresponding recipients of AMR plasmids to confirm the transfer of blaCTX-M and to detect any associated transfer of other resistance phenotypes. The assay used the disk-diffusion method on Mueller–Hinton agar plates following CLSI recommendations. The panel of antibiotic containing disks (Oxoid LTD, Basingstoke, Hampshire, England) along with their abbreviated names were amoxicillin-clavulanic acid (AMC-20/10 µg), cefoxitin (FOX-30 µg), cefotaxime (CTX-30 µg), ceftazidime (CAZ-30 µg), cefepime (CEF-30 µg), gentamicin (GEN-10 µg), amikacin (AMK-30 µg), ciprofloxacin (CIP-5 µg), meropenem (MEM-10 µg) and sulfamethoxazole/trimethoprim (SXT-23.75/1.25 µg). Susceptibility was interpreted according to CLSI document M100-S30 (CLSI, 2020). ESBL-negative E. coli ATCC 25,922 and ESBL-positive K. pneumoniae subsp. pneumoniae ATCC 700,603 (Microbiologics Inc., Saint Cloud, Minnesota, USA) were used as reference strains.

A PBRT protocol involving 18 primer pairs in 5 multiplex- and 3 simplex-reaction setups60 was used to identify AMR plasmid replicon types FIA, FIB, FIC, HI1, HI2, I1-Ig, L/M, N, P, W, T, A/C, K, B/O, X, Y, F, and FIIA.

Eight addiction systems were determined for the 75 parental donors and their respective recipient strains using previously described PCR primers pairs and amplification conditions19. These included the detection of three type I addiction systems [Hok-Sok (hok-sok) (host-killing), PndA-PndC (pndAC) (promotion of nucleic acid degradation), and SrnB-SrnC (srnBC) (stable RNA negative)] and five type II addiction systems [PemK-PemI (pemKI) (plasmid emergency maintenance), CcdA-CcdB (ccdAB) (coupled to cell division), RelB-RelE (relBE) (relaxed control stable RNA synthesis), ParD-ParE (parDE) (DNA replication), and VagC-VagD (vagCD) (virulence associated proteins)].

Detection of the insertion sequence ISEcp1 was determined by PCR using the combination of ISEcp1 primer and CTX-M reverse consensus primer (MA1 reverse) as previously described61. An amplified product is indicative of the ISEcp1 element situated upstream of the blaCTX-M genes. The PCR products were purified and confirmed by sequencing.

Biofilm formation was determined for 12 parental isolates. The isolates chosen and their detected genotypes and phenotypes are listed in Supplementary Table S1. All parental isolates belonged to the known extra-intestinal pathogenic E. coli (phylogenetic group B2 and D). All except isolate 149 are the international high-risk clone ST131. All produce at least one CTX-M type, and all except isolate 74 exhibited the detection of more than one IncF plasmid replicon type. The measurement of biofilm forming capacity of the parental isolates and their corresponding recipients used a previously described protocol with slight modification62. Briefly, both groups of bacteria were grown in M63 minimal media with glycerol as the carbon source, and with respective antibiotics overnight at 37 °C with aeration. Cefotaxime (2 µg/ml) was used for donor parental strains and 2 µg/ml cefotaxime and 100 µg/ml sodium azide were used for recipients. The strain E. coli J53 AziR was used as a control and grown in the M63 medium containing 100 µg/ml sodium azide. From overnight bacterial cultures, 3 µl aliquots were mixed with in 147 µl fresh M63 medium in the wells of a sterile 96-well round-bottom µl dish and incubated overnight at 37 °C. Developed biofilms were heat-fixed and stained with 0.1% w/v crystal violet solution. The stained biomass was recovered by solubilisation in 33% (v/v) glacial acetic acid. The extent of solubilized biofilm was then recorded spectroscopically at an absorbance of 560 nm, and the efficiency of biofilm formation calculated by normalization with planktonic growth recorded as the optical density at a wavelength of 600 nm. The specific biofilm formation (SBF) was determined using the formula SBF = (AB-CW)/G, where AB is OD560 of stained cells, CW is OD560 of control wells cultured with M63 medium only, and G is the OD600 of the bacteria growth calculated from G = OD600 (24 h)—OD600 (0 h). The strains were categorized as weak biofilm former (SBF ≤ 0.5), moderate biofilm former (SBF = 0.5–1.0) and strong biofilm former (SBF ≥ 1.0). For logistical reasons, the sample size was restricted to 12 to enable a minimum of three biological replicates with three technical repeats to ensure data quality. Furthermore, the selection process ensured that the parental isolates represented the different phylogenetic backgrounds.

Serum sensitivity was determined for 10 parental isolates and their corresponding trans-conjugants using a previously described protocol49. Briefly, the strains were grown in LB broth overnight at 37 \(^\circ\)C with aeration. Five µl of the overnight cultures were sub-cultured into 495 µl fresh LB broth and grown statically for 2 h at 37 \(^\circ\)C. Following centrifugation at 7600 g for 3 min, pellets were re-suspended in 500 µl phosphate-buffered saline. Volumes of 20 µl from the washed bacteria were mixed with 180 µl of normal human serum in a 96-well flat bottom microtiter dish and incubated statically at 37 °C for 3 h. At 0 h and 3 h time points, 20 µl was removed from the wells and plated after suitable serial dilution on LB plates containing 2 µg/ml cefotaxime for parental strains, 2 µg/ml cefotaxime and 100 µg/ml sodium azide for trans-conjugants, and 100 µg/ml sodium azide for the E. coli J53 AziR control. The number of colony forming units (CFUs) of bacteria was determined after the plates were incubated overnight at 37 °C. Susceptibility to active serum was calculated as follows: log kill = (log10 CFU/µl of initially added bacteria—0 h)—(log10 CFU/µl of bacteria surviving the incubation after 3 h) according to a previous report63. All experiments were conducted in duplicate. The selection process of the 10 isolates ensured that the parental isolates represented the different phylogenetic backgrounds. The recipient J53 strain alone was used as a control in all assays.

The data was prepared using Excel spread sheets (Microsoft Office) and imported to SPSS version 20.0. The frequencies of different variables were calculated. Cross-tabulation and graphs were used to present the different relation between data.

The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.

Antimicrobial resistance

African Society for Laboratory Medicine

Antimicrobial susceptibility test

β- Lactamase coding gene

Basic Local Alignment Tool

Colony forming unit

Clinical and Laboratory Standard Institution

Active on Cefotaxime, First Isolated at Munich

Ethiopian National Accreditation Office

Extended spectrum β-lactamases

Horizontal gene transfer

Institutional Review Board

Identification

Incompatibility

Insertion sequence

International Organization for Standardization

Lauria-Bertani Agar

Lauria-Bertani

Multilocus sequence typing

Oxacillinase

Specific biofilm formation

β-Lactamase enzyme named after sulphydryl variable

The stepwise laboratory quality improvement process towards accreditation

Sequencing type

β-Lactamase enzyme named after a Greek patient Temoniera

World Health, O. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. (2022).

Iredell, J., Brown, J. & Tagg, K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ 352, h6420. https://doi.org/10.1136/bmj.h6420 (2016).

Article CAS PubMed Google Scholar

De Angelis, G., Del Giacomo, P., Posteraro, B., Sanguinetti, M. & Tumbarello, M. Molecular mechanisms, epidemiology, and clinical importance of beta-lactam resistance in enterobacteriaceae. Int. J. Mol. Sci. 21, 1. https://doi.org/10.3390/ijms21145090 (2020).

Article CAS Google Scholar

Paterson, D. L. & Bonomo, R. A. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18, 657–686. https://doi.org/10.1128/CMR.18.4.657-686.2005 (2005).

Article CAS PubMed PubMed Central Google Scholar

Bevan, E. R., Jones, A. M. & Hawkey, P. M. Global epidemiology of CTX-M beta-lactamases: Temporal and geographical shifts in genotype. J. Antimicrob. Chemother. 72, 2145–2155. https://doi.org/10.1093/jac/dkx146 (2017).

Article CAS PubMed Google Scholar

Eckert, C., Gautier, V. & Arlet, G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J. Antimicrob. Chemother. 57, 14–23. https://doi.org/10.1093/jac/dki398 (2006).

Article CAS PubMed Google Scholar

Partridge, S. R., Kwong, S. M., Firth, N. & Jensen, S. O. Mobile genetic elements associated with antimicrobial resistance. Clin. Microbiol. Rev. 31, 1. https://doi.org/10.1128/CMR.00088-17 (2018).

Article Google Scholar

Escudeiro, P., Pothier, J., Dionisio, F. & Nogueira, T. Antibiotic resistance gene diversity and virulence gene diversity are correlated in human gut and environmental microbiomes. mSphere 4, 1. https://doi.org/10.1128/mSphere.00135-19 (2019).

Article Google Scholar

Schaufler, K. et al. Genomic and functional analysis of emerging virulent and multidrug-resistant escherichia coli lineage sequence type 648. Antimicrob. Agents Chemother. 63, 1. https://doi.org/10.1128/AAC.00243-19 (2019).

Article Google Scholar

Saravanan, M., Ramachandran, B. & Barabadi, H. The prevalence and drug resistance pattern of extended spectrum beta-lactamases (ESBLs) producing Enterobacteriaceae in Africa. Microb. Pathog. 114, 180–192. https://doi.org/10.1016/j.micpath.2017.11.061 (2018).

Article PubMed Google Scholar

Negeri, A. A. et al. Antimicrobial resistance profiling and molecular epidemiological analysis of extended spectrum β-lactamases produced by extraintestinal invasive Escherichia coli isolates from Ethiopia: the presence of international high-risk clones ST131 and ST410 revealed. Front. Microbiol. 12, 2159. https://doi.org/10.3389/fmicb.2021.706846 (2021).

Article Google Scholar

Bonnet, R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48, 1–14. https://doi.org/10.1128/AAC.48.1.1-14.2004 (2004).

Article CAS PubMed PubMed Central Google Scholar

Tsang, J. Bacterial plasmid addiction systems and their implications for antibiotic drug development. Postdoc. J. 5, 3–9 (2017).

PubMed PubMed Central Google Scholar

Engelberg-Kulka, H. & Glaser, G. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu. Rev. Microbiol. 53, 43–70. https://doi.org/10.1146/annurev.micro.53.1.43 (1999).

Article CAS PubMed Google Scholar

Stalder, T. & Top, E. Plasmid transfer in biofilms: A perspective on limitations and opportunities. NPJ Biofilms Microbiomes 2, 1. https://doi.org/10.1038/npjbiofilms.2016.22 (2016).

Article Google Scholar

Ranjan, A. et al. ESBL-plasmid carriage in E. coli enhances in vitro bacterial competition fitness and serum resistance in some strains of pandemic sequence types without overall fitness cost. Gut. Pathog. 10, 24. https://doi.org/10.1186/s13099-018-0243-z (2018).

Article CAS PubMed PubMed Central Google Scholar

Phan, M. D. et al. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet. 9, e1003834. https://doi.org/10.1371/journal.pgen.1003834 (2013).

Article CAS PubMed PubMed Central Google Scholar

Carattoli, A. et al. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63, 219–228. https://doi.org/10.1016/j.mimet.2005.03.018 (2005).

Article CAS PubMed Google Scholar

Mnif, B. et al. Molecular characterization of addiction systems of plasmids encoding extended-spectrum beta-lactamases in Escherichia coli. J. Antimicrob. Chemother. 65, 1599–1603. https://doi.org/10.1093/jac/dkq181 (2010).

Article CAS PubMed Google Scholar

Price, L. B. et al. The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4, e00377–00313. https://doi.org/10.1128/mBio.00377-13 (2013).

Tamang, M. D. et al. Molecular characterization of CTX-M beta-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farm workers, and the farm environment. Appl. Environ. Microbiol. 79, 3898–3905. https://doi.org/10.1128/AEM.00522-13 (2013).

Article ADS CAS PubMed PubMed Central Google Scholar

Cartelle, M. et al. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob. Agents Chemother. 48, 2308–2313. https://doi.org/10.1128/AAC.48.6.2308-2313.2004 (2004).

Article CAS PubMed PubMed Central Google Scholar

Rozwandowicz, M. et al. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J. Antimicrob. Chemother. 73, 1121–1137. https://doi.org/10.1093/jac/dkx488 (2018).

Article CAS PubMed Google Scholar

Villa, L., Garcia-Fernandez, A., Fortini, D. & Carattoli, A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65, 2518–2529. https://doi.org/10.1093/jac/dkq347 (2010).

Article CAS PubMed Google Scholar

Mathers, A. J., Peirano, G. & Pitout, J. D. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin. Microbiol. Rev. 28, 565–591. https://doi.org/10.1128/CMR.00116-14 (2015).

Article CAS PubMed PubMed Central Google Scholar

Johnson, T. J. et al. Separate F-type plasmids have shaped the evolution of the H30 subclone of escherichia coli sequence type 131. mSphere 1, 1. https://doi.org/10.1128/mSphere.00121-16 (2016).

Article CAS Google Scholar

Stephens, C. et al. F plasmids are the major carriers of antibiotic resistance genes in human-associated commensal Escherichia coli. mSphere 5, 1. https://doi.org/10.1128/mSphere.00709-20 (2020).

Article Google Scholar

Carattoli, A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53, 2227–2238. https://doi.org/10.1128/AAC.01707-08 (2009).

Article CAS PubMed PubMed Central Google Scholar

Drieux, L. et al. Complete nucleotide sequence of the large conjugative pTC2 multireplicon plasmid encoding the VIM-1 metallo-beta-lactamase. J. Antimicrob. Chemother. 68, 97–100. https://doi.org/10.1093/jac/dks367 (2013).

Article CAS PubMed Google Scholar

Tamang, M. D. et al. Prevalence and molecular characterization of CTX-M beta-lactamase-producing Escherichia coli isolated from healthy swine and cattle. Foodborne Pathog. Dis. 10, 13–20. https://doi.org/10.1089/fpd.2012.1245 (2013).

Article CAS PubMed Google Scholar

Jo, S. J. & Woo, G. J. Molecular characterization of plasmids encoding CTX-M beta-Lactamases and their Associated Addiction Systems Circulating Among Escherichia coli from Retail Chickens, Chicken Farms, and Slaughterhouses in Korea. J. Microbiol. Biotechnol. 26, 270–276. https://doi.org/10.4014/jmb.1507.07048 (2016).

Article CAS PubMed Google Scholar

Mnif, B. et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems. BMC Microbiol. 13, 147. https://doi.org/10.1186/1471-2180-13-147 (2013).

Article CAS PubMed PubMed Central Google Scholar

Doumith, M., Dhanji, H., Ellington, M. J., Hawkey, P. & Woodford, N. Characterization of plasmids encoding extended-spectrum beta-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. J. Antimicrob. Chemother. 67, 878–885. https://doi.org/10.1093/jac/dkr553 (2012).

Article CAS PubMed Google Scholar

Hayes, F. Toxins-antitoxins: Plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301, 1496–1499. https://doi.org/10.1126/science.1088157 (2003).

Article ADS CAS PubMed Google Scholar

Barton, B. M., Harding, G. P. & Zuccarelli, A. J. A general method for detecting and sizing large plasmids. Anal. Biochem. 226, 235–240. https://doi.org/10.1006/abio.1995.1220 (1995).

Article CAS PubMed Google Scholar

Douarre, P. E., Mallet, L., Radomski, N., Felten, A. & Mistou, M. Y. Analysis of COMPASS, a new comprehensive plasmid database revealed prevalence of multireplicon and extensive diversity of IncF plasmids. Front Microbiol 11, 483. https://doi.org/10.3389/fmicb.2020.00483 (2020).

Article PubMed PubMed Central Google Scholar

Shin, J., Choi, M. J. & Ko, K. S. Replicon sequence typing of IncF plasmids and the genetic environments of blaCTX-M-15 indicate multiple acquisitions of blaCTX-M-15 in Escherichia coli and Klebsiella pneumoniae isolates from South Korea. J. Antimicrob. Chemother. 67, 1853–1857. https://doi.org/10.1093/jac/dks143 (2012).

Article CAS PubMed Google Scholar

Yang, Q. E. et al. IncF plasmid diversity in multi-drug resistant Escherichia coli strains from animals in China. Front. Microbiol. 6, 964. https://doi.org/10.3389/fmicb.2015.00964 (2015).

Article PubMed PubMed Central Google Scholar

Dahmen, S., Metayer, V., Gay, E., Madec, J. Y. & Haenni, M. Characterization of extended-spectrum beta-lactamase (ESBL)-carrying plasmids and clones of Enterobacteriaceae causing cattle mastitis in France. Vet. Microbiol. 162, 793–799. https://doi.org/10.1016/j.vetmic.2012.10.015 (2013).

Article CAS PubMed Google Scholar

Fortini, D., Fashae, K., Garcia-Fernandez, A., Villa, L. & Carattoli, A. Plasmid-mediated quinolone resistance and beta-lactamases in Escherichia coli from healthy animals from Nigeria. J. Antimicrob. Chemother. 66, 1269–1272. https://doi.org/10.1093/jac/dkr085 (2011).

Article CAS PubMed Google Scholar

Zhang, C. et al. A phage-like IncY plasmid carrying the mcr-1 gene in escherichia coli from a Pig Farm in China. Antimicrob. Agents Chemother. 61, 1. https://doi.org/10.1128/AAC.02035-16 (2017).

Article Google Scholar

Puangseree, J., Prathan, R., Srisanga, S., Angkittitrakul, S. & Chuanchuen, R. Plasmid profile analysis of Escherichia coli and Salmonella enterica isolated from pigs, pork and humans. Epidemiol. Infect. 150, 110. https://doi.org/10.1017/S0950268822000814 (2022).

Article Google Scholar

Garcia-Fernandez, A., Fortini, D., Veldman, K., Mevius, D. & Carattoli, A. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J. Antimicrob. Chemother. 63, 274–281. https://doi.org/10.1093/jac/dkn470 (2009).

Article CAS PubMed Google Scholar

Carattoli, A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Int. J. Med. Microbiol. 301, 654–658. https://doi.org/10.1016/j.ijmm.2011.09.003 (2011).

Article CAS PubMed Google Scholar

Beyrouthy, R. et al. IS1R-mediated plasticity of IncL/M plasmids leads to the insertion of bla OXA-48 into the Escherichia coli Chromosome. Antimicrob. Agents Chemother. 58, 3785–3790. https://doi.org/10.1128/AAC.02669-14 (2014).

Article CAS PubMed PubMed Central Google Scholar

Omar, K. B. & Barnard, T. G. Detection of diarrhoeagenic Escherichia coli in clinical and environmental water sources in South Africa using single-step 11-gene m-PCR. World J. Microbiol. Biotechnol. 30, 2663–2671. https://doi.org/10.1007/s11274-014-1690-4 (2014).

Article CAS PubMed PubMed Central Google Scholar

Perichon, B. et al. Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux. Antimicrob. Agents Chemother. 52, 2581–2592. https://doi.org/10.1128/AAC.01540-07 (2008).

Article CAS PubMed PubMed Central Google Scholar

Norton, J. P. & Mulvey, M. A. Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog 8, e1002954. https://doi.org/10.1371/journal.ppat.1002954 (2012).

Hussain, A. et al. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-beta-lactamase-producing lineage. Antimicrob. Agents Chemother. 56, 6358–6365. https://doi.org/10.1128/AAC.01099-12 (2012).

Article CAS PubMed PubMed Central Google Scholar

Johnson, J. R. & Russo, T. A. Molecular epidemiology of extraintestinal pathogenic Escherichia coli. EcoSal Plus 8, 1. https://doi.org/10.1128/ecosalplus.ESP-0004-2017 (2018).

Article Google Scholar

Sora, V. M. et al. Extraintestinal pathogenic Escherichia coli: Virulence factors and antibiotic resistance. Pathogens 10, 1. https://doi.org/10.3390/pathogens10111355 (2021).

Article CAS Google Scholar

Rojas-Lopez, M., Monterio, R., Pizza, M., Desvaux, M. & Rosini, R. Intestinal pathogenic Escherichia coli: Insights for vaccine development. Front. Microbiol. 9, 440. https://doi.org/10.3389/fmicb.2018.00440 (2018).

Article PubMed PubMed Central Google Scholar

Vila, J. et al. Escherichia coli: An old friend with new tidings. FEMS Microbiol. Rev. 40, 437–463. https://doi.org/10.1093/femsre/fuw005 (2016).

Article CAS PubMed Google Scholar

Vrancianu, C. O., Popa, L. I., Bleotu, C. & Chifiriuc, M. C. Targeting plasmids to limit acquisition and transmission of antimicrobial resistance. Front. Microbiol. 11, 761. https://doi.org/10.3389/fmicb.2020.00761 (2020).

Article PubMed PubMed Central Google Scholar

Williams, J. J. & Hergenrother, P. J. Exposing plasmids as the Achilles’ heel of drug-resistant bacteria. Curr. Opin. Chem. Biol. 12, 389–399. https://doi.org/10.1016/j.cbpa.2008.06.015 (2008).

Article CAS PubMed PubMed Central Google Scholar

Ibrahim, R. A. et al. Antimicrobial resistance surveillance in Ethiopia: Implementation experiences and lessons learned. Afr. J. Lab. Med. 7, 770. https://doi.org/10.4102/ajlm.v7i2.770 (2018).

Article PubMed PubMed Central Google Scholar

Kue, J. et al. Standardizing clinical culture specimen collection in Ethiopia: a training-of-trainers. BMC Med. Educ. 21, 195. https://doi.org/10.1186/s12909-021-02631-w (2021).

Article PubMed PubMed Central Google Scholar

Hamprecht, A. et al. Pathogenicity of clinical OXA-48 isolates and impact of the OXA-48 IncL plasmid on virulence and bacterial fitness. Front. Microbiol. 10, 2509. https://doi.org/10.3389/fmicb.2019.02509 (2019).

Article PubMed PubMed Central Google Scholar

Dallenne, C., Da Costa, A., Decre, D., Favier, C. & Arlet, G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65, 490–495. https://doi.org/10.1093/jac/dkp498 (2010).

Article CAS PubMed Google Scholar

Clermont, O., Christenson, J. K., Denamur, E. & Gordon, D. M. The Clermont Escherichia coli phylo-typing method revisited: Improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 5, 58–65. https://doi.org/10.1111/1758-2229.12019 (2013).

Article CAS PubMed Google Scholar

Eckert, C. et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48, 1249–1255. https://doi.org/10.1128/AAC.48.4.1249-1255.2004 (2004).

Article CAS PubMed PubMed Central Google Scholar

Hossain, M. et al. Genotype-phenotype correlation of beta-lactamase-producing uropathogenic Escherichia coli (UPEC) strains from Bangladesh. Sci. Rep. 10, 14549. https://doi.org/10.1038/s41598-020-71213-5 (2020).

Article ADS CAS PubMed PubMed Central Google Scholar

Mouammine, A. et al. Ail and PagC-related proteins in the entomopathogenic bacteria of Photorhabdus genus. PLoS One 9, e110060. https://doi.org/10.1371/journal.pone.0110060 (2014).

Download references

Authors would like to acknowledge those people who participated in the specimen collection as well as EPHI clinical bacteriology and Mycology national reference laboratory staff for their initial identification and characterization of the isolates, all as part of the national AMR surveillance program. The authors also thank Stephan Göttig (Klinikum der Johann Wolfgang Goethe-Universität) for providing the bacterial strain E coli J53 AziR.

Open access funding provided by Umea University. Aspects of this work was supported partly by the Medical Foundation of Umeå University and partly by the Swedish Research Council—Medicine and Health (grant numbers 2014–06652 and 2018–02676).

National Clinical Bacteriology and Mycology Reference Laboratory, Ethiopian Public Health Institute, Addis Ababa, Ethiopia

Abebe Aseffa Negeri

Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia

Abebe Aseffa Negeri & Hassen Mamo

Department of Molecular Biology, Umeå University, Umeå, Sweden

Abebe Aseffa Negeri, Dharmender K. Gahlot, Jyoti M. Gurung & Matthew S. Francis

Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden

Dharmender K. Gahlot, Jyoti M. Gurung & Matthew S. Francis

Global One Health Initiative of the Ohio State University, East African Regional Office, Addis Ababa, Ethiopia

Eyasu Tigabu Seyoum

You can also search for this author in PubMed Google Scholar

A.A.N. designed the study, preformed the experiments, and wrote the initial manuscript draft; H.M. designed the study, and performed supervision; D.K.G. preformed biofilm experiments, data analysis and figure preparation; J.M.G. performed supervision, data analysis, and figure preparation; E.T.S. preformed phenotypic experiments and provided technical insight; M.S.F. designed the study, performed supervision, acquired funding and revised the manuscript. All authors read and approved the final manuscript.

Correspondence to Matthew S. Francis.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

Negeri, A.A., Mamo, H., Gahlot, D.K. et al. Characterization of plasmids carrying blaCTX-M genes among extra-intestinal Escherichia coli clinical isolates in Ethiopia. Sci Rep 13, 8595 (2023). https://doi.org/10.1038/s41598-023-35402-2

Download citation

Received: 07 July 2022

Accepted: 16 May 2023

Published: 26 May 2023

DOI: https://doi.org/10.1038/s41598-023-35402-2

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Convert MP4 to MP3 on Mac in these Top 4 Ways [2023]

Orange Amps offers analog warmth with its first line of Bluetooth speakers

News

Characterization of plasmids carrying blaCTX